Tumour cells produce receptor activator of NF-kappaB ligand (RANKL) in skeletal metastases.
Huang
L
L
Cheng
Y Y
YY
Chow
L T C
LT
Zheng
M H
MH
Kumta
S M
SM
D000230:Adenocarcinoma / Q000556:secondary*; D001859:Bone Neoplasms / Q000556:secondary*; D002352:Carrier Proteins / Q000378:metabolism*; D005260:Female; D006801:Humans; D008024:Ligands; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism*; D010014:Osteolysis / Q000378:metabolism; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B
D002352:Carrier Proteins; D008024:Ligands; D008562:Membrane Glycoproteins; D016328:NF-kappa B; D009363:Neoplasm Proteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human